Clinical Trial Update: SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating the SmartAdjust 2.0 System for managing Type 1 and Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SmartAdjust 2.0 System

Snippet

Sponsor: Insulet Corporation | Conditions: Diabetes Mellitus | NA | Status: COMPLETED